Popular on Rezul
- No Limits Method Revolutionizes Neurodivergent Education Through Embodied Cognition - 110
- Corner Property Management Welcomes Seneca Reserve HOA! - 106
- Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado - 101
- First AI Marketing Platform Built Specifically for Small Businesses Launches Public Beta
- TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy
- Manhattan Boutique Real Estate Collaborates with InterContinental Hotels NYC in a Branding Partners Personalized Approach
- Honoring Black History, Culture, and Community in Fall River
- Token-Operated Sake Service Opens at Tobu Nikko Station
- Real Estate CEO Launches Explosive New Book After $275,784 Wire Fraud Incident
- Cheryl Hines' Trailer PROWLING to Sardinia
Similar on Rezul
- Clarity for Arizona Landowners Feeling Stuck or Unsure
- Mikel DeFrancesco Named RealTrends Top Realtor in Quincy, Milton & South Shore MA
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Networking For A Cause - NYC Professionals come together to network for a cause
- "Navigating Florida's New Condo Laws: What Central Florida Owners & Buyers Need to Know"
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Walnut Hills Launches Off-Grid Hempcrete Homes and Eco-Retreat in Western NC
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Nevada Real Estate Agent David Crane Helping Families Find Their Dream Home
- Garden City Realty recognizes top REALTOR®s of the Month and Quarter
CytoSorbents to Become NBP's Newest Tenant at College Park at Princeton Forrestal Center
Rezul News/10515447
PRINCETON, N.J. - Rezul -- Joining a variety of renowned life science and research and development firms with offices and laboratory space at National Business Park's College Park at Princeton Forrestal Center, CytoSorbents Corporation, a publicly traded medical device company, has leased just over 48,000 square feet at 305 College Road East for its research and development, product assembly, and administrative offices. Represented by Avison Young, the company expects to take occupancy of the space in June 2021, and will occupy almost the entire building, which previously housed another biotechnology firm. CytoSorbents is the ideal company to occupy one of National Business Parks' premier research and development spaces in College Park.
CytoSorbents uses its proprietary blood purification technology to treat life-threatening conditions in the intensive care unit or during high-risk surgery. Its flagship product, CytoSorb®, is approved in the European Union and distributed in 67 countries around the world to treat deadly inflammation that can otherwise rapidly lead to organ failure and death. CytoSorb was granted FDA Emergency Use Authorization for use in the United States for use in COVID-19 patients in the ICU, where CytoSorb is used to treat critically ill patients that have developed "cytokine storm" as a result of the virus. The device is also used to treat many other conditions including, for example, complications of cardiac surgery, trauma, and liver disease.
Vincent Capponi, MS, President and Chief Operating Officer of CytoSorbents commented, "We are incredibly pleased to work with National Business Parks to lease the facility at 305 College Road East, which has a solid existing infrastructure to meet our unique operational needs. With other modifications that will be made to the space, we will be able to consolidate all of our operations in one building and allow the launch of new product lines. The changes we are planning will also allow us to increase our CytoSorb production from our current $80 million annual capacity to approximately $300 to $400 million annually to support our future growth while allowing us to achieve further economies of scale."
More on Rezul News
According to Vincent Marano, Chief Operating Officer of National Business Parks, "We look forward to welcoming CytoSorbents to our 305 College Road East property early this summer. We are excited to work closely with CytoSorbents to customize the space to be the perfect combination of laboratory, device assembly, and administrative offices. We could not be more pleased that CytoSorbents has chosen our research and development community at College Park to fit its current needs, as well as provide for its future growth."
College Park at Princeton Forrestal Center, located just off the Route 1 corridor in Princeton, boasts some of the best class-A office, laboratory, biotechnology, and research and development office space in the area. Managed by National Business Parks, Inc., College Park at Princeton Forrestal Center is one of the area's most award-winning office complexes. For more information on College Park please visit their website at http://nationalbusinesspks.com/ or call 609-452-1300.
# # #
About CytoSorbents Corporation
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 67 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorb® has been used in more than 121,000 human treatments to date. CytoSorb has received CE-Mark label expansions for the removal of bilirubin (liver disease), myoglobin (trauma), and both ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorb has also received FDA Emergency Use Authorization in the United States for use in critically ill COVID-19 patients with imminent or confirmed respiratory failure, in defined circumstances. CytoSorb has also been granted FDA Breakthrough Designation (https://c212.net/c/link/?t=0&l=en&o=309...) for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery.
More on Rezul News
CytoSorbents uses its proprietary blood purification technology to treat life-threatening conditions in the intensive care unit or during high-risk surgery. Its flagship product, CytoSorb®, is approved in the European Union and distributed in 67 countries around the world to treat deadly inflammation that can otherwise rapidly lead to organ failure and death. CytoSorb was granted FDA Emergency Use Authorization for use in the United States for use in COVID-19 patients in the ICU, where CytoSorb is used to treat critically ill patients that have developed "cytokine storm" as a result of the virus. The device is also used to treat many other conditions including, for example, complications of cardiac surgery, trauma, and liver disease.
Vincent Capponi, MS, President and Chief Operating Officer of CytoSorbents commented, "We are incredibly pleased to work with National Business Parks to lease the facility at 305 College Road East, which has a solid existing infrastructure to meet our unique operational needs. With other modifications that will be made to the space, we will be able to consolidate all of our operations in one building and allow the launch of new product lines. The changes we are planning will also allow us to increase our CytoSorb production from our current $80 million annual capacity to approximately $300 to $400 million annually to support our future growth while allowing us to achieve further economies of scale."
More on Rezul News
- Networking For A Cause - NYC Professionals come together to network for a cause
- "Navigating Florida's New Condo Laws: What Central Florida Owners & Buyers Need to Know"
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Walnut Hills Launches Off-Grid Hempcrete Homes and Eco-Retreat in Western NC
According to Vincent Marano, Chief Operating Officer of National Business Parks, "We look forward to welcoming CytoSorbents to our 305 College Road East property early this summer. We are excited to work closely with CytoSorbents to customize the space to be the perfect combination of laboratory, device assembly, and administrative offices. We could not be more pleased that CytoSorbents has chosen our research and development community at College Park to fit its current needs, as well as provide for its future growth."
College Park at Princeton Forrestal Center, located just off the Route 1 corridor in Princeton, boasts some of the best class-A office, laboratory, biotechnology, and research and development office space in the area. Managed by National Business Parks, Inc., College Park at Princeton Forrestal Center is one of the area's most award-winning office complexes. For more information on College Park please visit their website at http://nationalbusinesspks.com/ or call 609-452-1300.
# # #
About CytoSorbents Corporation
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 67 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorb® has been used in more than 121,000 human treatments to date. CytoSorb has received CE-Mark label expansions for the removal of bilirubin (liver disease), myoglobin (trauma), and both ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorb has also received FDA Emergency Use Authorization in the United States for use in critically ill COVID-19 patients with imminent or confirmed respiratory failure, in defined circumstances. CytoSorb has also been granted FDA Breakthrough Designation (https://c212.net/c/link/?t=0&l=en&o=309...) for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery.
More on Rezul News
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
- The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
- Digital Watchdog Launches New myDW Cloud Services
Source: National Business Parks Management
Filed Under: Real Estate, Property
0 Comments
Latest on Rezul News
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Dedeaux Properties Begins Construction on Truck Terminal and Industrial Outdoor Storage Facility
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- Paulding County's Old Mill Preserve Now Open to the Public in Georgia
- Kramer Real Estate: The Boutique Brokerage Quietly Taking Over North Texas
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Salazar Heating, Cooling & Plumbing Launches Water Conservation Initiative to Help Santa Fe Homeowners Cut Water Waste
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Winners Development Corporation Pioneers Skyscraper In South Dallas
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
- Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings